相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial
Corinne Faivre-Finn et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach
Sanjay Popat et al.
ONCOLOGIST (2021)
Factors influencing multi-disciplinary tumor board recommendations in stage III non-small cell lung cancer
Merle I. Ronden et al.
LUNG CANCER (2021)
A systematic review and meta-analysis of treatment-related toxicities of curative and palliative radiation therapy in non-small cell lung cancer
M. Or et al.
SCIENTIFIC REPORTS (2021)
Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients
Judi N. A. van Diessen et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
K. Park et al.
ANNALS OF ONCOLOGY (2020)
The Dutch Lung Cancer Audit: Nationwide quality of care evaluation of lung cancer patients
R. K. Ismail et al.
LUNG CANCER (2020)
Targeted Intervention to Improve the Quality of Head and Neck Radiation Therapy Treatment Planning in the Netherlands: Short and Long-Term Impact
Wilko F. A. R. Verbakel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer
Katelyn M. Atkins et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Stage III Non-small Cell Lung Cancer Management in England
J. B. Adizie et al.
CLINICAL ONCOLOGY (2019)
Radiation Therapy Quality Assurance (RTQA) of Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer in the PROCLAIM Phase 3 Trial
Anthony M. Brade et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer
Ursula Nestle et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database
Eric D. Miller et al.
RADIATION ONCOLOGY (2018)
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
Stephen G. Chun et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Heart Dose Is an Independent Dosimetrie Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer
Christina K. Speirs et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy
Matthew Koshy et al.
LUNG CANCER (2017)
Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry
C. Dickhoff et al.
LUNG CANCER (2017)
Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base
Naresh Jegadeesh et al.
CLINICAL LUNG CANCER (2016)
PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer
Suresh Senan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Population-Based Patterns of Surgical Care for Stage IIIA NSCLC in the Netherlands between 2010 and 2013
Chris Dickhoff et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy
Azza A. Khalil et al.
ACTA ONCOLOGICA (2015)
Improving radiotherapy planning for large volume lung cancer: A dosimetric comparison between hybrid-IMRT and RapidArc
Gerrit J. Blom et al.
ACTA ONCOLOGICA (2015)
Changes in non-surgical management of stage III non-small cell lung cancer at a single institution between 2003 and 2010
Ellen J. F. van Reij et al.
ACTA ONCOLOGICA (2014)
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. Vansteenkiste et al.
ANNALS OF ONCOLOGY (2013)
Predicting Esophagitis After Chemoradiation Therapy for Non-Small Cell Lung Cancer: An Individual Patient Data Meta-Analysis
David A. Palma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Predicting Radiation Pneumonitis After Chemoradiation Therapy for Lung Cancer: An International Individual Patient Data Meta-analysis
David A. Palma et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Clinical Application of a Novel Hybrid Intensity-Modulated Radiotherapy Technique for Stage III Lung Cancer and Dosimetric Comparison With Four Other Techniques
Wilko F. A. R. Verbakel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Proton Radiation Therapy Offers Reduced Normal Lung and Bone Marrow Exposure for Patients Receiving Dose-Escalated Radiation Therapy for Unresectable Stage III Non-Small-Cell Lung Cancer: A Dosimetric Study
R. Charles Nichols et al.
CLINICAL LUNG CANCER (2011)
New developments in arc radiation therapy: A review
David A. Palma et al.
CANCER TREATMENT REVIEWS (2010)
INFLUENCE OF TECHNOLOGIC ADVANCES ON OUTCOMES IN PATIENTS WITH UNRESECTABLE, LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER RECEIVING CONCOMITANT CHEMORADIOTHERAPY
Zhongxing X. Liao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
INTENSITY-MODULATED PROTON THERAPY REDUCES THE DOSE TO NORMAL TISSUE COMPARED WITH INTENSITY-MODULATED RADIATION THERAPY OR PASSIVE SCATTERING PROTON THERAPY AND ENABLES INDIVIDUALIZED RADICAL RADIOTHERAPY FOR EXTENSIVE STAGE IIIB NON-SMALL-CELL LUNG CANCER: A VIRTUAL CLINICAL STUDY
Xiaodong Zhang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Concurrent chemoradiotherapy in non-small cell lung cancer
Noelle O'Rourke et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2010)
Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer
Joe Y. Chang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
分享论文
